Tag: oncology

December 21, 2021 Off

Sanofi will acquire Amunix for an upfront payment of approximately $1 billion

By Dino Mustafić

Sanofi will acquire Amunix for an upfront payment of approximately $1 billion and up to $225 million upon achievement of certain future development milestones. The acquisition supports Sanofi’s efforts to accelerate and expand its contributions to innovative medicines for oncology patients, with approximately 20 molecules currently in development. 

December 17, 2020 Off

Merck’s supplemental BLA in priority review for Keytruda chemotherapy combo

By BusinessWire

The FDA has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with platinum and fluoropyrimidine based chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic carcinoma of the esophagus and gastroesophageal junction